Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
Conditions
Glioblastoma · Radiotherapy Side Effect
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Olv Azorg, Aalst, Belgium
Contact: Principal Investigator (Samuel Bral, MD)Benedikt Engels, MD (Sub-investigator)EpiCURA, Baudour, Belgium
Contact: Principal Investigator (Serge Ndam, MD)AZ Sint Jan, Bruges, Belgium
Contact: Principal Investigator (Martijn Swimberghe, MD)Institut Jules Bordet, Brussels, Belgium
Contact: Study coordinator (Secretary office) · accueil.cons.radiotherapie@hubruxelles.be · +32 2 541 38 00Contact: Principal Investigator (Philippe Martinive, MD)UZ Brussel, Brussels, Belgium
Contact: Principal Investigator (Selma Ben Mustapha, MD)Cliniques universitaires Saint-Luc, Brussels, Belgium
Contact: Principal Investigator (Dario Di Perri, MD)Nicolas Whenham, MD (Sub-investigator)Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium
Contact: Principal Investigator (Mieke Govers, MD)Annelies Maes, MD (Sub-investigator)Anne-Sophe Van de Velde, MD (Sub-investigator)AZ Sint-Lucas, Ghent, Belgium
Contact: Principal Investigator (Wim Duthoy)UZ Gent, Ghent, Belgium
Contact: Study coordinator (Secretary office) · secretariaat.radiotherapie@uzgent.be · +32 9 332 30 15Contact: Principal Investigator (Tom Boterberg, MD)Grand Hôpital de Charleroi, Gilly, Belgium
Contact: Principal Investigator (Benjamin Ledoux, MD)JESSA Ziekenhuis, Hasselt, Belgium
Contact: Principal Investigator (Anne-Sophe Van de Velde, MD)Annelies Maes, MD (Sub-investigator)Mieke Govers, MD (Sub-investigator)AZ Groeninge, Kortrijk, Belgium
Contact: Principal Investigator (Nick Liefhooghe, MD)Isabelle Kindts, MD (Sub-investigator)Chu Helora, La Louvière, Belgium
Contact: Principal Investigator (Samuel Palumbo, MD)UZ Leuven, Leuven, Belgium
Contact: Principal Investigator (Maarten Lambrecht, MD)CHU Liège, Liège, Belgium
Contact: Principal Investigator (Lisa Grandjean, MD)AZ Sint Maarten, Mechelen, Belgium
Contact: Principal Investigator (Julie Van der Veen, MD)Valerie Vandeputte, MD (Sub-investigator)Hôpital André Vésale - HUmani, Montigny-le-Tilleul, Belgium
Contact: Principal Investigator (Martin Manderlier, MD)Pauline Semoulin, MD (Sub-investigator)CH Mouscron, Mouscron, Belgium
Contact: Study coordinator (Secretary office) · secretariat.radiotherapie@chmouscron.be · +32 56 85 83 60Contact: Principal Investigator (Katrien Thevissen, MD)Anne-Emmanuelle Yeo, MD (Sub-investigator)CHU UCL Namur - Sainte Elisabeth, Namur, Belgium
Contact: Principal Investigator (Marie Wanet, MD)AZ Delta, Roeselare, Belgium
Contact: Principal Investigator (Caroline Sweldens, MD)Lien Van De Voorde, MD (Sub-investigator)Cliniques de l'Europe, Uccle, Belgium
Contact: Principal Investigator (Dorothée Berben, MD)CHR Verviers, Verviers, Belgium
Contact: Principal Investigator (David Devillers, MD)ZAS Augustinus, Wilrijk, Belgium
Contact: Principal Investigator (Carole Mercier, MD)
Study leads
Dario Di Perri, MD
Principal Investigator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain